Cargando…
Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma
Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplasms. We report a case of a woman with a history of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517839/ https://www.ncbi.nlm.nih.gov/pubmed/23243547 http://dx.doi.org/10.1155/2012/208606 |
_version_ | 1782252480819625984 |
---|---|
author | Graceffa, D. Maiani, E. Pace, A. Solivetti, F. M. Elia, F. De Mutiis, C. Bonifati, C. |
author_facet | Graceffa, D. Maiani, E. Pace, A. Solivetti, F. M. Elia, F. De Mutiis, C. Bonifati, C. |
author_sort | Graceffa, D. |
collection | PubMed |
description | Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplasms. We report a case of a woman with a history of severe psoriasis who developed psoriatic arthritis during a course of bevacizumab, which was administered for a malignant glioma. |
format | Online Article Text |
id | pubmed-3517839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-35178392012-12-14 Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma Graceffa, D. Maiani, E. Pace, A. Solivetti, F. M. Elia, F. De Mutiis, C. Bonifati, C. Case Rep Rheumatol Case Report Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplasms. We report a case of a woman with a history of severe psoriasis who developed psoriatic arthritis during a course of bevacizumab, which was administered for a malignant glioma. Hindawi Publishing Corporation 2012 2012-11-29 /pmc/articles/PMC3517839/ /pubmed/23243547 http://dx.doi.org/10.1155/2012/208606 Text en Copyright © 2012 D. Graceffa et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Graceffa, D. Maiani, E. Pace, A. Solivetti, F. M. Elia, F. De Mutiis, C. Bonifati, C. Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma |
title | Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma |
title_full | Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma |
title_fullStr | Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma |
title_full_unstemmed | Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma |
title_short | Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma |
title_sort | psoriatic arthritis during treatment with bevacizumab for anaplastic oligodendroglioma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517839/ https://www.ncbi.nlm.nih.gov/pubmed/23243547 http://dx.doi.org/10.1155/2012/208606 |
work_keys_str_mv | AT graceffad psoriaticarthritisduringtreatmentwithbevacizumabforanaplasticoligodendroglioma AT maianie psoriaticarthritisduringtreatmentwithbevacizumabforanaplasticoligodendroglioma AT pacea psoriaticarthritisduringtreatmentwithbevacizumabforanaplasticoligodendroglioma AT solivettifm psoriaticarthritisduringtreatmentwithbevacizumabforanaplasticoligodendroglioma AT eliaf psoriaticarthritisduringtreatmentwithbevacizumabforanaplasticoligodendroglioma AT demutiisc psoriaticarthritisduringtreatmentwithbevacizumabforanaplasticoligodendroglioma AT bonifatic psoriaticarthritisduringtreatmentwithbevacizumabforanaplasticoligodendroglioma |